ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
74 hedge funds and large institutions have $70.5M invested in Anthera Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
14% less call options, than puts
Call options by funds: $558K | Put options by funds: $651K
15% less capital invested
Capital invested by funds: $83M → $70.5M (-$12.5M)
Holders
74
Holding in Top 10
3
Calls
$558K
Puts
$651K
Top Buyers
| 1 | +$1.51M | |
| 2 | +$731K | |
| 3 | +$463K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$297K |
| 5 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$232K |
Top Sellers
| 1 | -$2.56M | |
| 2 | -$1.61M | |
| 3 | -$417K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$306K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$301K |